Recent Articles from Business Wire

Voyager Awarded NASA CLPS 2 Contract
Voyager Technologies (NYSE: VOYG) has been selected under NASA's new Commercial Lunar Payload Services Multiple Award Contract (MAC) IDIQ — commonly referred to as CLPS 2 — officially onboarding the company into the next-generation CLPS vendor pool. The company is eligible to compete for future NASA lunar mission task orders through 2036 under a base contract ceiling of $10 billion, with an option to extend to 2041 with an increased ceiling of $15 billion.
By Voyager Technologies · Via Business Wire · November 7, 2026
ispace-U.S. Selected to Support NASA Moon Base Program
ispace technologies U.S., Inc. ("ispace-U.S."), the Colorado-based American entity of ispace, inc. ("ispace"), today confirmed it has been selected for NASA's Commercial Lunar Payload Services 2 (CLPS 2) Indefinite Delivery, Indefinite Quantity (IDIQ) master contract. The selection makes ispace-U.S. eligible to compete for future NASA task orders as a prime contractor, providing end-to-end payload transportation and lunar surface operations using the company's ULTRA lander and future lander designs.
By ispace technologies U.S., Inc. · Via Business Wire · November 7, 2026
DOX Investors Have Opportunity to Join Amdocs Limited Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Amdocs Limited (“Amdocs” or “the Company”) (NASDAQ: DOX) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 7, 2026
SYY Investors Have Opportunity to Join Sysco Corporation Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sysco Corporation (“Sysco” or “the Company”) (NYSE: SYY) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 7, 2026
Recording Academy® and Grammy Museum® Honor Local Teachers Across United States as 2027 Music Educator Award™ Finalists
Grammy Museum
By Grammy Museum · Via Business Wire · November 7, 2026
Berkshire Hathaway Inc. News Release
(BRK.A; BRK.B) –
By Berkshire Hathaway Inc. · Via Business Wire · November 7, 2026
Arrowhead Pharmaceuticals Presents Plozasiran Data Highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis Rates
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented results on two of the RNA interference (RNAi) based therapies in its cardiometabolic pipeline at the American Heart Association (AHA) Scientific Sessions 2026 in Chicago. The presentations included multiple studies of plozasiran in patients with familial chylomicronemia syndrome (FCS) and severe hypertriglyceridemia (sHTG), and interim results from a Phase 1/2a study of investigational ARO-DIMER-PA in patients with mixed hyperlipidemia.
By Arrowhead Pharmaceuticals, Inc. · Via Business Wire · November 7, 2026
QumulusAI to Report Third Quarter 2026 Financial Results on Nov. 10, 2026
QumulusAI (Nasdaq: QMLS), a neocloud infrastructure provider purpose-built for the AI computing era, today announced that it will report financial results for the third quarter ended Sept. 30, 2026 after market close on Tuesday, Nov. 10, 2026, and will host a conference call and webcast at 5 p.m. EST the same day to discuss the results.
By QumulusAI · Via Business Wire · November 7, 2026
PARAMOUNT, the First Randomized Trial of AI-Enabled Plaque-Based Care, Meets Primary Endpoint in Late-Breaking Results at AHA 2026
Cleerly, a leader in advanced cardiovascular imaging analysis, today presented primary results from PARAMOUNT, the first randomized trial of AI-QCT-guided care against usual care, as Late-Breaking Science at the American Heart Association (AHA) Scientific Sessions 2026 in Chicago. Compared with usual care based on stress testing, care guided by AI-based quantitative coronary CT analysis (AI-QCT) improved diagnostic certainty and led to more patients receiving lipid-lowering therapy.
By Cleerly · Via Business Wire · November 7, 2026
PTC Stock Alert: Halper Sadeh LLC is Investigating Whether PTC Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of PTC Inc. (NASDAQ: PTC) to Schneider Electric for $205.00 per share in cash.
By Halper Sadeh LLC · Via Business Wire · November 7, 2026
APP Deadline: Rosen Law Firm Urges AppLovin Corporation (NASDAQ: APP) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of AppLovin Corporation (NASDAQ: APP) between February 12, 2026 and August 5, 2026, inclusive (the “Class Period”). AppLovin provides AI-powered advertising solutions.
By The Rosen Law Firm, P.A. · Via Business Wire · November 7, 2026
DOCS Deadline: Rosen Law Firm Urges Doximity, Inc. (NYSE: DOCS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action on behalf of purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026. Doximity describes itself as a “digital platform for medical professionals that combines health care news, workflow products, and clinician networking.”
By The Rosen Law Firm, P.A. · Via Business Wire · November 7, 2026
New Real-World Evidence Presented by Organon at the American College of Rheumatology (ACR) Annual Meeting Evaluated a Large-Scale Switch to HADLIMA® (adalimumab-bwwd) Across United States Veterans Affairs Healthcare System
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced the poster presentation of new real-world evidence at the American College of Rheumatology (ACR) Annual Meeting, held November 6-11, 2026 in Orlando, Florida. The poster evaluates the treatment, management, and economic impacts of transitioning patients from originator HUMIRA® (adalimumab) to biosimilar HADLIMA® (adalimumab-bwwd) within the United States (US) Department of Veterans Affairs (VA) Healthcare System.1
By Organon & Co. · Via Business Wire · November 7, 2026
Aqtual Presents Data Linking Blood-Based Biomarkers to Tissue Biology and Treatment Response in Rheumatoid Arthritis
Aqtual, Inc., a precision medicine company developing active chromatin cell-free DNA (cfDNA) diagnostics, today announced data that advance the understanding of why patients with rheumatoid arthritis (RA) respond differently to treatment and support the continued development of Aqtual’s RA treatment selection test, a blood-based biomarker test designed to help physicians choose among TNF inhibitors, JAK inhibitors, and abatacept for patients with RA before starting or switching treatment. Two posters being presented at the American College of Rheumatology (ACR) Convergence 2026, November 6–10 in Orlando, Florida, show that signals detected in blood reflect joint tissue biology associated with response to different RA medications, and that participants in Aqtual’s prospective PRIMA-102 study (NCT05936970) can be linked to real-world data to extend follow-up. Aqtual is also exhibiting at ACR at Booth #4119.
By Aqtual, Inc. · Via Business Wire · November 7, 2026
BIDU Deadline: Rosen Law Firm Urges Baidu, Inc. (NASDAQ: BIDU) Investors with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Baidu, Inc. (NASDAQ: BIDU) between November 18, 2025 and August 17, 2026, inclusive (the “Class Period”). Baidu is a Chinese technology company.
By The Rosen Law Firm, P.A. · Via Business Wire · November 7, 2026
TTAN INVESTIGATION ALERT: Investigation Launched into ServiceTitan, Inc., Robbins Geller Rudman & Dowd LLP Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
Robbins Geller Rudman & Dowd LLP is investigating potential violations of United States federal securities laws involving ServiceTitan, Inc. (NASDAQ: TTAN).
By Robbins Geller Rudman & Dowd LLP · Via Business Wire · November 6, 2026
Investor Alert: Robbins LLP Informs Investors of the Kinross Gold Corporation Class Action Lawsuit
Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons who purchased or otherwise acquired Kinross Gold Corporation (NYSE: KGC) common stock between February 18, 2026 and September 23, 2026, inclusive (the “Class Period”). Kinross is a Canadian gold mining company headquartered in Toronto, Ontario, with regional offices and mining facilities in the United States and abroad.
By Robbins LLP · Via Business Wire · November 6, 2026
KaliVir Immunotherapeutics Reports 71% Objective Response Rate in Patients with Advanced, Cutaneous Malignancies in Phase 1/1b STEALTH-001 Trial
KaliVir Immunotherapeutics, Inc., a clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs, today announced preliminary clinical results from its Phase 1/1b STEALTH-001 trial evaluating intratumoral VET3-TGI alone or in combination with atezolizumab (NCT06444815) in patients with advanced solid tumors. The objective response rate (ORR) was 71% (5 of 7) in the response-evaluable cutaneous cancer subgroup and 41.7% (5 of 12) across the overall response-evaluable population. All seven patients with cutaneous cancers had progressed on prior anti-PD-1/PD-L1 therapy.
By KaliVir Immunotherapeutics, Inc. · Via Business Wire · November 6, 2026
KBRA Assigns Preliminary Ratings to FMC GMSR Issuer Trust, Series 2026-GT2 (FMC GMSR 2026-GT2)
KBRA assigns preliminary ratings of ‘BBB- (sf)’ to the Series 2026-GT2, Class A Term Notes from FMC GMSR ISSUER TRUST, Freedom Mortgage Corporation’s (FMC) master trust issuer of notes backed by a participation certificate evidencing a participation interest in mortgage servicing rights (MSR) on loans underlying Ginnie Mae guaranteed mortgage backed securities.
By Kroll Bond Rating Agency, LLC · Via Business Wire · November 6, 2026
AngioDynamics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the grant of inducement awards to Eric Honroth in connection with his appointment as Chief Executive Officer of the Company effective as of November 2, 2026.
By AngioDynamics, Inc. · Via Business Wire · November 6, 2026
bioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercialization
bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease and topically delivered therapeutics for skin cancer, today reported financial results and business highlights for the third quarter (Q3) ended September 30, 2026.
By bioAffinity Technologies, Inc. · Via Business Wire · November 6, 2026
Stensul Debuts Self-Improving Email for Enterprise Marketers
Stensul, the AI governance platform for enterprise email marketing, today announced its November release, which extends governance to campaign performance. The release introduces Self-Improving Email, now in early access, which connects the performance of every email to the specific content inside it, so each new send learns from the last.
By Stensul · Via Business Wire · November 6, 2026
LIME Investors Have Opportunity to Join Neutron Holdings, Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Neutron Holdings, Inc. d/b/a Lime (“Lime” or “the Company”) (NASDAQ: LIME) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 6, 2026
SovAI Joins NVIDIA Inception to Build Behind-the-Meter AI Factories to the NVIDIA DSX Reference Architecture
SovAI, Inc. (“SovAI”), The AI Factory Architect, today announced that it has joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technology advancements. SovAI designs, builds and operates sovereign, behind-the-meter AI Factories — campuses built on Sovereign Fuel, Sovereign Power and Sovereign Compute — to NVIDIA’s published DSX reference architecture, and orchestrates them with Scotty, its operating engineer for AI Factories.
By SovAI, Inc. · Via Business Wire · November 6, 2026
AM Best Affirms Credit Ratings of Central States Indemnity Co. of Omaha and Its Subsidiary
AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Ratings of “aa-” (Superior) of Central States Indemnity Co. of Omaha (CSI), and its subsidiary, CSI Life Insurance Company (CSI Life), collectively referred to as CSI. The outlook of these Credit Ratings (ratings) is stable. Both companies are domiciled in Omaha, NE.
By AM Best · Via Business Wire · November 6, 2026
AM Best Affirms Credit Ratings of AMEX Assurance Company
AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a+” (Excellent) of AMEX Assurance Company (AMEX) (Chicago, IL). The outlook of these Credit Ratings (ratings) is stable.
By A.M. Best Rating Services, Inc. · Via Business Wire · November 6, 2026
Faraday Future Plans to Hold a Special Meeting of Stockholders on December 15 to Seek Approval of Key Proposals
Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future,” “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today announced that it plans to hold a Special Meeting of Stockholders (the “Special Meeting”) on December 15, 2026, subject to confirmation, to seek approval of a Reverse Stock Split Proposal and an Adjournment Proposal.
Santander Holdings USA, Inc. Announces Preferred Dividend and Redemption of All Outstanding Depositary Shares Representing Interests in Its Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series H
Santander Holdings USA, Inc. (“SHUSA”) today announced that its Board of Directors declared a quarterly cash dividend of $328.125 per share ($0.328125 per each depositary share (the “Depositary Shares”), NYSE: SNUS PF H, CUSIP 80282 K700, 1,000 of which represents one preferred share) on its Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series H (“Series H Preferred Stock”), payable December 15, 2026, to shareholders of record on November 30, 2026.
By Santander Holdings USA, Inc. · Via Business Wire · November 6, 2026
Coeur to Participate in RBC Capital Markets London Precious Metals Conference
Coeur Mining, Inc.’s (“Coeur” or the “Company”) (NYSE, TSX: CDE) Executive Vice President and Chief Financial Officer, Thomas S. Whelan, will participate in the RBC Capital Markets Precious Metals Conference in London, United Kingdom on Tuesday, November 10, 2026.
By Coeur Mining · Via Business Wire · November 6, 2026
Copper Property CTL Pass Through Trust Issues Monthly Reporting Package for October 2026
Copper Property CTL Pass Through Trust (“the Trust”) has filed a Form 8-K containing its monthly report for the period ended October 31, 2026. An aggregate total distribution of $6.6 million or $0.087583 per trust certificate will be paid on November 10, 2026, to certificateholders of record as of November 9, 2026.
Bloom Energy Supports Oxford Firefighters and Local Families Ahead of Georgia-Ole Miss Matchup
Bloom Energy (NYSE: BE) continued its season-long partnership with ESPN Radio's College Football Campus Tour this week in Oxford, Mississippi, ahead of Saturday's Georgia-Ole Miss matchup.
By Bloom Energy · Via Business Wire · November 6, 2026
KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-14 (SEMT 2026-14)
KBRA assigns preliminary ratings to 102 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-14 (SEMT 2026-14), a $451.0 million prime RMBS transaction. The pool comprises 370 first-lien, fully amortizing, fixed-rate mortgages, primarily with 30-year maturity terms. The collateral has a weighted average (WA) original credit score of 773 and moderate borrower equity, with a WA original LTV and WA original CLTV of 70.1% and 70.1%, respectively.
By Kroll Bond Rating Agency, LLC · Via Business Wire · November 6, 2026
Urban Edge Properties Declares a Quarterly Common Dividend of $0.21 per Share
Urban Edge Properties (NYSE: UE) announced today that its Board of Trustees has declared a regular quarterly dividend of $0.21 per common share. The dividend will be payable on December 31, 2026 to common shareholders of record on December 15, 2026.
By Urban Edge Properties · Via Business Wire · November 6, 2026
Acker's Birthday Auction to Feature the Cellar of London Collector Lewis Chester DipWSET
Acker, America's oldest wine merchant and the world's largest fine wine auction house, will present a distinguished selection of 595 lots led by the private family collection of Lewis Chester DipWSET as a centerpiece of its three-day Birthday Auction, taking place November 19–21. The wider auction will feature more than 3,400 lots, with an aggregate estimate exceeding $20 million. Chester's collection will go under the hammer on Thursday, November 19, at 3:30pm ET, coinciding with Acker's BYO “Birthday” Bash & Bidding Party in New York City, which will also celebrate Chairman John Kapon's 55th birthday.
By Acker · Via Business Wire · November 6, 2026
Hagens Berman: McDonald’s Sued for Allegedly Mislabeling “Sugar Free” McCafé Beverages, Violating Federal Regulations
Consumers hit McDonald’s with a class-action lawsuit accusing it of mislabeling eight of its McCafé coffee beverages as “sugar free” despite them containing up to 18 grams of sugar, which attorneys allege violates federal regulations and consumer-protection laws, according to Hagens Berman and co-counsel Sterlington PLLC.
By Hagens Berman Sobol Shapiro LLP · Via Business Wire · November 6, 2026
Dumpling Time Expands Beyond California with First Idaho Location at Boise's Warehouse Food Hall
Omakase Restaurant Group (ORG), the San Francisco-based hospitality group behind Michelin-starred Niku Steakhouse and Boise's Raibu Sushi Bar, is bringing its popular Dumpling Time concept to Idaho. Opening Friday, November 6, at the Warehouse Food Hall in downtown Boise, the new location marks Dumpling Time's first expansion outside the San Francisco Bay Area and ORG's second restaurant in Idaho.
By Omakase Restaurant Group · Via Business Wire · November 6, 2026
Triumph to Present at the Stephens Annual Investment Conference on November 17, in Nashville, Tennessee
Triumph Financial, Inc. (NYSE: TFIN) today announced that Aaron Graft, vice chairman and chief executive officer, will present at the Stephens Annual Investment Conference on Nov. 17, 2026, in Nashville, Tennessee. Triumph’s presentation is scheduled to begin at 1:15 p.m. CT. The presentation will be webcast live and may be accessed through this direct link, https://event.summitcast.com/view/AnJcL7fjsXraGqV8XG6fRL/nzKfnZSXNuauLhsG8pJgqX or via the Company's website at ir.triumph.io through the News & Events, Events & Presentations links.
By Triumph Financial, Inc. · Via Business Wire · November 6, 2026
ProShares to Launch ANTU and ANTY ETFs Targeting 2x and -2x Daily Returns of Anthropic following its IPO
ProShares, the world’s leader in geared (leveraged and inverse) investing, today announced plans to launch two ETFs targeting 2x and -2x daily returns of Anthropic, following the company’s IPO. These ETFs are designed for investors looking to magnify a bullish or bearish view on Anthropic.
By ProShares · Via Business Wire · November 6, 2026
Corpay to Participate in Upcoming Investor Conferences
Corpay, Inc., (NYSE: CPAY), the Global Spend Management Company, today announced that the Company will participate in the following investor conferences:
By Corpay, Inc. · Via Business Wire · November 6, 2026
HEI Reports Third Quarter 2026 Results
Hawaiian Electric Industries, Inc. (NYSE - HE) (HEI) today reported net income for the third quarter of 2026 of $35 million, or $0.20 per share, compared to net income of $31 million, or $0.18 per share in the third quarter of 2025. The quarter’s results include $64 million of realized and unrealized pre-tax gains related to HEI’s investment in American Savings Bank (ASB) and a non-cash $51 million pre-tax asset impairment recorded at Pacific Current. (See “Holding Company and Other Segment” section of this release for further detail on ASB and Pacific Current-related impacts.) Excluding these impacts, and excluding Maui wildfire-related items, Core net income for the quarter was $23 million, or $0.13 per share, compared to $33 million, or $0.19 per share in the third quarter of 2025. Both GAAP and Core net income include $14 million of estimated incremental pre-tax costs related to storm activity in August and September.
lululemon Appoints Ben Hallam as Chief Brand Officer to Strengthen Global Brand and Guest Experience
lululemon athletica inc. (NASDAQ: LULU) today announced the appointment of Ben Hallam as Chief Brand Officer, effective November 9, 2026. Mr. Hallam will join the company's Senior Leadership Team and report to Chief Executive Officer Heidi O'Neill. He most recently served as Senior Vice President of Marketing at Four Seasons Hotels and Resorts.
By lululemon athletica inc. · Via Business Wire · November 6, 2026
Kardigan Completes Enrollment in Phase 2b KATALYST-AV Trial and Announces New Evidence Supporting Patient Selection and Endpoints for the Evaluation of Ataciguat in Aortic Stenosis
Kardigan®, Inc. (Nasdaq: KARD), a precision cardiovascular company, today announced enrollment completion in the Phase 2b KATALYST-AV trial of ataciguat in people with aortic stenosis (AS). The Company also shared insights from a pre-planned analysis of the trial’s baseline data, as well as new evidence on disease progression from one of the largest real-world analyses conducted in approximately 45,000 people with AS. These analyses support the primary endpoint assessment of aortic valve calcium (AVC) at Week 48, alongside measures of cardiac structure and function, and an internal interim analysis at Week 24.
By Kardigan, Inc. · Via Business Wire · November 6, 2026
Fortune Brands to Participate in Baird’s 2026 Global Industrial Conference
Fortune Brands Innovations, Inc. (NYSE: FBIN) (“Fortune Brands” or the “Company”), an industry-leading home, security and digital products company, today announced that Jesse Singh, Chief Executive Officer, and Pete Clifford, Chief Financial Officer, will participate in a fireside chat at Baird’s 2026 Global Industrial Conference on Tuesday, November 10, 2026, at 10:15 a.m. Central Time.
By Fortune Brands Innovations, Inc. · Via Business Wire · November 6, 2026
Dutch Bros Appoints Kira Druyan as Incoming Chief Legal Officer
Dutch Bros Inc. (NYSE: BROS) ("Dutch Bros" or the "Company"), one of the fastest-growing brands in the U.S. quick-service beverage industry, today announced the appointment of Kira Druyan as Incoming Chief Legal Officer. Reporting to Christine Barone, Chief Executive Officer and President, Druyan will oversee the Company's legal affairs, corporate governance and compliance functions.
By Dutch Bros Inc. · Via Business Wire · November 6, 2026
Knight-Swift Transportation Holdings Inc. Announces Quarterly Cash Dividend
Knight-Swift Transportation Holdings Inc. (NYSE: KNX) (the "Company" or "Knight-Swift") announced today that its board of directors ("the Board") has declared the Company’s quarterly cash dividend of $0.20 per share of common stock. The Company's quarterly dividends are pursuant to a cash dividend policy approved by the Board. The actual declaration of future cash dividends, and the establishment of record and payment dates, is subject to final determination by the Board each quarter after its review of the Company’s financial performance.
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the award of inducement grants.
By CareDx, Inc. · Via Business Wire · November 6, 2026
Viridian Therapeutics to Host Conference Call to Present VRDN-008 Phase 1 Data and FcRn Portfolio Plans on November 9, 2026
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for autoimmune and rare diseases, today announced it will host a conference call and webcast to present data from the VRDN-008 phase 1 clinical trial in healthy volunteers and development plans for its neonatal Fc receptor (FcRn) portfolio on Monday, November 9, 2026, at 8:00 a.m. ET.
By Viridian Therapeutics, Inc. · Via Business Wire · November 6, 2026
Link Logistics Surpasses $10 Million Donated Through Community Grants Program
Link Logistics (the “Company”), a leading operator of last-mile industrial real estate and warehouse properties, today announced it has invested more than $10 million through its employee-led Community Grants Program since launching the initiative in 2022. This milestone underscores the Company’s commitment to supporting local organizations and strengthening the communities where it operates.
By Link Logistics · Via Business Wire · November 6, 2026
Faeth to Report PIK-201 Phase 2 Data and Host Virtual Event on November 9, 2026
Faeth Therapeutics (Nasdaq: FTH), a clinical- stage biotechnology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced that it will host a virtual event on Monday, November 9 at 8:00 AM ET to discuss topline results from its Phase 2 PIK-201 trial exploring PIKTOR in advanced endometrial cancer. To register, click here.
By Faeth Therapeutics, Inc. · Via Business Wire · November 6, 2026
Bristol Myers Squibb Presents 56-Week Phase 3 Data in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) for Camzyos (mavacamten) at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions
Bristol Myers Squibb (NYSE: BMY) today presented 56-week results from the Phase 3 SCOUT-HCM clinical trial in a late-breaker presentation at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions, taking place November 6, 2026, in Chicago, Illinois. The SCOUT-HCM clinical trial evaluated the efficacy and safety of Camzyos (mavacamten) in pediatric patients aged 12 to <18 years with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). These additional data build upon confidence in Camzyos, which has the broadest indication of any cardiac myosin inhibitor (CMI) and is the first CMI approved for pediatric patients with symptomatic oHCM. Results from the 56-week data are consistent with previously reported 28-week results from the trial. Bristol Myers Squibb will be sharing additional presentations that add to the breadth of clinical and real-world data supporting the use of Camzyos across patient populations, reinforcing the consistent efficacy and safety profile of Camzyos as a treatment for symptomatic oHCM, at the American Heart Association’s Scientific Sessions 2026 taking place November 6 – 9, 2026, in Chicago, Illinois.
By Bristol Myers Squibb · Via Business Wire · November 6, 2026
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a clinical-stage targeted oncology company focused on developing first-in-class and best-in-class cancer therapies, announced today that on November 2, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 206,700 shares of common stock and 103,350 restricted stock units (“RSUs”) to seventeen new employees under the Company’s 2024 Inducement Plan. The Compensation Committee approved the awards as an inducement material to such employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).
By Immunome, Inc. · Via Business Wire · November 6, 2026
Mueller Industries, Inc. Declares Cash Dividend for Fourth Quarter
Mueller Industries, Inc. (NYSE: MLI) announced today that its Board of Directors has declared a regular quarterly cash dividend on its common stock of 17.5 cents per share. The dividend will be payable December 18, 2026 to shareholders of record on December 4, 2026.
By Mueller Industries, Inc. · Via Business Wire · November 6, 2026
G&H Acquires IntraAction to Scale Acousto-Optics for Semiconductor Growth
G&H (Gooch & Housego), a leading provider of advanced photonics solutions, today announced its acquisition of IntraAction Corp., bringing together two established businesses with a long heritage in acousto-optic technology.
By Gooch & Housego · Via Business Wire · November 6, 2026
CBRS Investors Have Opportunity to Join Cerebras Systems Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cerebras Systems Inc. (“Cerebras” or “the Company”) (NASDAQ: CBRS) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 6, 2026
TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tenax Therapeutics, Inc. (“Tenax” or “the Company”) (NASDAQ: TENX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 6, 2026
ASTS Deadline: Rosen Law Firm Urges AST SpaceMobile, Inc. (NASDAQ: ASTS) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of AST SpaceMobile, Inc. (NASDAQ: ASTS) between March 4, 2025 and July 15, 2026, inclusive (the “Class Period”). AST SpaceMobile designs and develops the constellation of BlueBird (“BB”) satellites.
By The Rosen Law Firm, P.A. · Via Business Wire · November 6, 2026
Cleveland-Cliffs Reaches New Four-Year Labor Agreements with United Steelworkers
Cleveland-Cliffs Inc. (NYSE:CLF) today announced that it has reached new four-year labor agreements with the United Steelworkers (USW) across its operating footprint. The agreements cover approximately 12,000 USW-represented employees across the Company’s steel plants and mining operations in Indiana, Ohio, Pennsylvania, Minnesota, and Michigan. The agreements resolve all USW labor contracts currently up for renewal.
By Cleveland-Cliffs Inc. · Via Business Wire · November 6, 2026
Egan Nelson Secures Top-Tier Honors in 2027 Best Law Firms Guide
Dallas-based boutique law firm Egan Nelson LLP is proud to announce it has earned widespread recognition in the 2027 edition of Best Law Firms.
By Egan Nelson LLP · Via Business Wire · November 6, 2026
Alpha Cognition to Participate in Upcoming Investor Events
Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company developing and commercializing novel therapeutics for debilitating neurodegenerative disorders, today announced that Michael McFadden, Chief Executive Officer, and Lauren D’Angelo, Chief Operating Officer, will participate in the upcoming investor events:
By Alpha Cognition Inc. · Via Business Wire · November 6, 2026
NASDAQ: MDGL INVESTIGATION ALERT: Madrigal Pharmaceuticals, Inc. Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP
Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Madrigal Pharmaceuticals, Inc. (“Madrigal”) (NASDAQ: MDGL) on behalf of investors who purchased or acquired Madrigal securities and experienced significant financial losses.
HGP Intelligent Energy Moves to Bring More Power from Existing Nuclear Plants, Submits Letter of Intent to NRC
HGP Intelligent Energy, LLC ("HGP"), a nuclear technology company, today announced it has submitted a letter of intent to the U.S. Nuclear Regulatory Commission (NRC), the first formal step toward regulatory review of its technology for pressurized water reactors, the most common type of U.S. nuclear plant.
By HGP Intelligent Energy, LLC · Via Business Wire · November 6, 2026
Balsam Hill and Brite Nites Partner to Bring Custom Outdoor Holiday Lighting to Homes
Balsam Hill®, a global leader in high-quality, true-to-nature, reusable, artificial Christmas trees and holiday décor, proudly announces a new partnership with Brite Nites, a premier provider of professional holiday lighting services, bringing a complete outdoor holiday lighting experience to customers.
By Balsam Hill · Via Business Wire · November 6, 2026
CW Advisors Accelerates Growth with Three Coast-to-Coast Acquisitions
CW Advisors, LLC (“CWA”), a Boston-based registered investment advisor (“RIA”), has acquired Yosemite Capital Management, LLC (“Yosemite”), Threadgill Financial, LLC (“Threadgill”), and Peddock Capital Advisors, LLC (“Peddock”). The Peddock transaction also included the acquisition of Peddock Tax Services, LLC, a full-service tax practice that provides clients with enhanced access to additional tax resources.
By CW Advisors, LLC · Via Business Wire · November 6, 2026
Nordson Corporation Announces Earnings Release and Webcast for Fourth Quarter and Fiscal Year 2026
Nordson Corporation (Nasdaq: NDSN) today announced it will release fourth quarter and fiscal year 2026 earnings on December 15, 2026, after the close of the market. Nordson will host its quarterly webcast on:
By Nordson Corporation · Via Business Wire · November 6, 2026
AM Best Affirms Credit Ratings of Mercantil Seguros y Reaseguros, S.A.
AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” (Good) of Mercantil Seguros y Reaseguros, S.A. (Mercantil Seguros) (Panama). The outlook of these Credit Ratings (ratings) is stable.
By AM Best · Via Business Wire · November 6, 2026
First U.S. Convintro™ Herbicide Delivery Launches a New Weed-Control Option for Corn and Soybean Growers
Bayer today marked the first U.S. delivery of Convintro™ herbicide, transported from its Kansas City manufacturing facility to New Century FS in Ruthven, Iowa. The milestone moves a new pre-emergent weed-control option closer to corn and soybean growers for the 2027 season.
By Bayer · Via Business Wire · November 6, 2026
First American Financial Corporation to Participate in the Stephens Annual Investment Conference
First American Financial Corporation (NYSE: FAF), a premier provider of title, settlement and risk solutions for real estate transactions and the leader in the digital transformation of its industry, today announced that Chief Executive Officer Mark Seaton and Chief Financial Officer Matthew Wajner will participate in a fireside chat at the Stephens Annual Investment Conference in Nashville, Tenn. on Tuesday, Nov. 17, 2026 at 3:45 p.m. EST.
AM Best Affirms Credit Ratings of Mercantil Reaseguradora Internacional, S.A.
AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” (Good) of Mercantil Reaseguradora Internacional, S.A. (Mercantil Re) (Panama). The outlook of these Credit Ratings (ratings) is stable.
By AM Best · Via Business Wire · November 6, 2026
Community Meeting Answers Questions for More Than 100 Participants as They Prepare to Submit Claims to SCE’s Wildfire Recovery Compensation Program
With the Nov. 30 deadline approaching to submit a claim to Southern California Edison’s Wildfire Recovery Compensation Program, SCE is continuing to provide opportunities for community members impacted by the Eaton Fire to learn about the program, ask questions and get help submitting a claim.
By Southern California Edison · Via Business Wire · November 6, 2026
National Life Group Approves $23 Million Dividends for 2027
The National Life Group Board of Directors has approved an estimated payment of $23 million in dividends to eligible participating policyholders in 2027. This payment represents National Life Group’s ongoing commitment to its policyholders and continues the proud heritage of having paid dividends since 1855.
By National Life Group · Via Business Wire · November 6, 2026
Deadline Alert: O-I Glass, Inc. Stockholders Face December 28, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights
O-I Glass, Inc. ("O-I Glass" or the "Company") (NYSE: OI) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 28, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from March 14, 2025 through July 28, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Bryan v. O-I Glass, Inc. et al., which was filed on October 29, 2026 in the U.S. District Court Ohio Northern District Court (Case No. 3:26-cv-02849).
By Law Offices of Howard G. Smith · Via Business Wire · November 6, 2026
Align Technology Recognized in Extel’s 2026 All-America Executive Team Rankings
Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced recognition in the 2026 All-America Executive Team rankings published by Extel Insights (formerly Institutional Investor Research), which evaluates the quality of investor relations programs, leadership, and governance as voted on by the buy- and sell-side analyst community. In the Health Care Technology & Distribution sector, Align earned first- and second-place rankings across three Large-Cap award categories – Best CEO, Best IR Program, and Best Investor Day – in both the Combined and Buy-side results. The 2026 awards mark Align’s fourth recognition in five years in the Extel All-America Executive Team rankings, reflecting the company’s longstanding commitment to transparent disclosure, meaningful investor engagement, and ongoing dialogue with shareholders and analysts.
By Align Technology, Inc. · Via Business Wire · November 6, 2026
Milliman analysis: Corporate pension funded ratio sees year’s largest monthly drop during October
Milliman, Inc., a premier global consulting and actuarial firm, today released its monthly Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans.
By Milliman, Inc. · Via Business Wire · November 6, 2026
ASTS Deadline in 7 Days: AST SpaceMobile, Inc. Class Action Lawsuit Seeks Recovery for Investors; November 13, 2026 Deadline- Contact Kessler Topaz Meltzer & Check, LLP
Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against AST SpaceMobile, Inc. (AST) (NASDAQ: ASTS) on behalf of those who purchased or acquired AST securities between March 4, 2025 and July 15, 2026, inclusive. The lawsuit is filed in the United States District Court for the Western District of Texas and is captioned Hunter v. AST SpaceMobile, Inc., No. 26-cv-00378 (W.D. Tex.). Investors have until November 13, 2026, to file for lead plaintiff status.
AM Best Upgrades Issuer Credit and National Scale Ratings of Auna Seguros, S.A.
AM Best has upgraded the Long-Term Issuer Credit Rating to “bbb+” (Good) from “bbb” (Good), the Mexico National Scale Rating (NSR) to “aa+.MX” (Superior) from “aa.MX” (Superior), and affirmed the Financial Strength Rating of B++ (Good) of Auna Seguros, S.A. (Auna Seguros) (Mexico). The outlook of these Credit Ratings (ratings) is stable.
By AM Best · Via Business Wire · November 6, 2026